Tempus

Through groundbreaking technology, Tempus AI, Inc. is revolutionizing precision medicine by harnessing the power of data and artificial intelligence in healthcare. At Tempus, the core mission is to ensure each patient benefits from the collective experience of those who came before them. This is achieved by providing physicians with sophisticated tools that continuously learn and improve as more data is gathered. The company has developed an extensive operating system designed to make vast libraries of clinical and molecular data accessible and actionable for patients, physicians, and researchers. This innovative platform enables healthcare providers to make near real-time, data-driven decisions, facilitating personalized patient care. Tempus's proprietary technology has allowed it to amass one of the world's largest libraries of clinical and molecular oncology data.

Tempus's innovation extends beyond oncology, with applications in neuropsychiatry, cardiology, infectious diseases, and radiology. The company's approach involves integrating unique patient information, including clinical, molecular, and imaging data, to enhance the intelligence of their tests and the insightfulness of their results. By embedding AI, including generative AI, throughout every facet of diagnostics, Tempus empowers physicians and researchers to make personalized, data-driven decisions that significantly improve patient care. This commitment to advancing healthcare is further demonstrated through collaborations with leading cancer centers, community hospitals, and biopharmaceutical companies to foster discovery, development, and delivery of optimal therapeutics. Tempus is dedicated to building a future where data and AI drive the next generation of personalized medicine, ultimately aiming to improve patient outcomes globally across all disease areas.